Table 5 OLS and linear probability estimates for SEP-health gradients among Cuban aged 18–65: NSRFCD 2010 (with sociodemographics)

1. SRH

Model 1

3.535*

5.249*

−0.536

1.695

1.886

1.091

− 0.051

[1.329,5.741]

[3.050,7.448]

[−3.021,1.950]

[−1.646,5.037]

[− 0.716,4.489]

[− 0.299,2.480]

[−1.883,1.781]

Model 2

3.181

4.726*

−0.159

1.584.

1.332

1.112

− 0.132

[0.825,5.536]

[2.455,6.997]

[−2.466,2.149]

[−1.637,4.806]

[− 1.221,3.885]

[− 0.305,2.528]

[− 1.968,1.704]

2. Hypertension

Model 1

0.037

0.029

0.011

0.035

0.028

0.003

0.060*

[−0.007,0.080]

[− 0.008,0.067]

[− 0.044,0.066]

[− 0.054,0.124]

[− 0.033,0.090]

[− 0.041,0.046]

[0.018,0.101]

Model 2

0.033

0.024

0.014

0.036

0.025

0.003

0.059*

[−0.015,0.081]

[−0.020,0.068]

[− 0.041,0.068]

[− 0.052,0.125]

[− 0.038,0.088]

[− 0.040,0.047]

[0.017,0.101]

3. General obesity

Model 1

−0.018

− 0.022

0.064

0.018

0.029

0.012

0.041

[−0.055,0.019]

[−0.059,0.014]

[0.017,0.110]

[−0.026,0.062]

[− 0.005,0.062]

[− 0.019,0.043]

[− 0.029,0.112]

Model 2

−0.013

− 0.015

0.063

0.020

0.030

0.012

0.043

[−0.052,0.026]

[−0.049,0.020]

[0.017,0.109]

[−0.023,0.063]

[− 0.005,0.065]

[− 0.019,0.043]

[− 0.027,0.112]

4. Abdominal obesity

Model 1

− 0.036

− 0.006

0.003

− 0.012

0.011

0.015

0.013

[−0.099,0.026]

[−0.076,0.065]

[− 0.113,0.118]

[− 0.121,0.097]

[− 0.084,0.106]

[− 0.038,0.068]

[− 0.055,0.082]

Model 2

− 0.040

− 0.011

0.003

−0.012

0.011

0.015

0.012

[−0.106,0.026]

[−0.087,0.066]

[− 0.110,0.115]

[− 0.119,0.096]

[− 0.089,0.111]

[− 0.038,0.068]

[− 0.055,0.079]

5. High glucose

Model 1

−0.024

− 0.021

0.052

0.030

0.036

−0.013

0.009

[−0.086,0.039]

[−0.086,0.044]

[0.005,0.100]

[−0.013,0.072]

[0.005,0.067]

[−0.044,0.017]

[− 0.032,0.051]

Model 2

−0.023

− 0.020

0.051

0.030

0.038

−0.013

0.008

[−0.084,0.037]

[−0.077,0.037]

[0.003,0.099]

[−0.015,0.074]

[0.009,0.066]

[−0.045,0.018]

[− 0.033,0.049]

6. High cholesterol

Model 1

−0.007

−0.010

− 0.034

−0.028

− 0.037

−0.066*

0.040

[−0.084,0.071]

[−0.094,0.073]

[− 0.104,0.037]

[− 0.157,0.100]

[−0.146,0.073]

[− 0.098,-0.033]

[− 0.083,0.163]

Model 2

− 0.002

−0.007

− 0.038

−0.032

− 0.042

−0.066*

0.042

[−0.067,0.063]

[−0.089,0.075]

[− 0.123,0.047]

[− 0.169,0.105]

[−0.162,0.078]

[− 0.097,-0.035]

[− 0.082,0.166]

7. High triglycerides

Model 1

0.017

−0.032

0.052

−0.022

−0.005

− 0.023

−0.078

[−0.109,0.143]

[−0.145,0.082]

[− 0.091,0.194]

[− 0.179,0.136]

[− 0.130,0.121]

[− 0.090,0.043]

[− 0.163,0.007]

Model 2

0.027

−0.015

0.055

−0.019

0.003

−0.028

− 0.080

[−0.092,0.147]

[− 0.120,0.091]

[− 0.091,0.200]

[− 0.182,0.144]

[− 0.123,0.130]

[− 0.093,0.038]

[−0.163,0.003]

8. Low HDL cholesterol

Model 1

0.076

0.135

−0.034

0.085

0.086

0.065

0.134

[−0.108,0.261]

[−0.077,0.346]

[− 0.166,0.098]

[− 0.431,0.600]

[0.035,0.137]

[− 0.063,0.192]

[−0.074,0.343]

Model 2

0.052

0.077

−0.047

0.075

0.071

0.076

0.133

[−0.218,0.323]

[−0.227,0.382]

[− 0.193,0.099]

[− 0.570,0.720]

[− 0.002,0.144]

[− 0.042,0.194]

[− 0.053,0.318]

9. Metabolic syndrome

Model 1

− 0.040

−0.011

0.106

−0.022

0.090

0.029

0.063

[−0.299,0.219]

[−0.280,0.259]

[− 0.118,0.331]

[− 0.258,0.213]

[0.003,0.176]

[− 0.097,0.155]

[− 0.006,0.131]

Model 2

−0.055

− 0.026

0.095

−0.042

0.076

0.029

0.060

[−0.240,0.130]

[−0.199,0.146]

[− 0.103,0.293]

[− 0.229,0.145]

[− 0.017,0.169]

[− 0.087,0.145]

[0.003,0.116]

10. One CVD risk factor

Model 1

−0.047

−0.007

− 0.032

0.103

0.025

0.047

0.024

[− 0.166,0.072]

[−0.063,0.048]

[− 0.622,0.558]

[− 0.360,0.566]

[− 0.534,0.584]

[− 0.086,0.179]

[− 0.106,0.153]

Model 2

− 0.051

− 0.027

− 0.039

0.094

0.020

0.056

0.027

[−0.177,0.075]

[−0.088,0.033]

[− 0.640,0.563]

[− 0.376,0.563]

[− 0.570,0.610]

[− 0.096,0.207]

[− 0.137,0.192]